Watch the conversation between Jeffrey Friedland and Bob Hoban on President Donald Trump, Attorney General Jeff Sessions and the Future of America’s Marijuana Policy.
About Robert Hoban
Bob Hoban is a Denver-based attorney whose practice is focused on cannabis legal issues. He is also Principal and Owner at Solana Business Solutions, which offers comprehensive consulting, management, regulatory, and product solutions services for the entire commercial cannabis industry – serving both THC, CBD and hemp business models.
In 2016, Mr. Hoban was selected as a member of the Boulder Colorado inaugural Marijuana Policy Advisory Committee and asked to serve on the Colorado Department of Agriculture's Industrial Hemp Advisory Committee. Former President of the Cannabis Business Alliance, Mr. Hoban was also a member of the Colorado Medical Marijuana Enforcement Division Rules Committee and is currently a member of the National Hemp Association, National Cannabis Industry Association and Colorado Cannabis Chamber of Commerce. In addition, Bob was involved as a drafter of Colorado’s marijuana regulatory legislation and has drafted over 30 bills for the Colorado General Assembly.
Mr. Hoban is a professor at the University of Denver in the Law and Society Program and regularly instructs regarding cannabis and hemp related legal and policy topics. He also teaches government regulations, public policy and research-based policy courses. In 2014, he led a University-sanctioned research practicum concerning the efficacy of marijuana regulation; the first of its kind in the U.S. This course resulted in a publication entitled "Sprung from Night into the Sun: An Examination of Colorado’s Marijuana Regulatory Framework," published in the December, 2015 edition of the Kentucky Journal of Equine, Agriculture, & Natural Resources Law.
In August 2015, he taught an international travel course in Uruguay concerning that country's landmark cannabis regulatory framework http://kdvr.com/2015/12/10/du-students-travel-to-uruguay-to-learn-about-the-cannabis-culture/.
In September, 2015, Mr. Hoban was hired by the University College of Professional and Continuing Studies at D.U. to develop and instruct medical marijuana and related regulatory courses in its Healthcare Leadership graduate program. He will instruct a multi student research practicum in the Winter of 2016 concerning the legal, policy, and regulatory framework surrounding the rebirth of industrial hemp. Because of this work, Mr. Hoban has worked with numerous state, local and international governments in developing both marijuana and industrial hemp regulations. As part of this effort, Bob has drafted more than 30 bills for the Colorado General Assembly (eminent domain/land use, hemp/marijuana and transportation).
Hoban Law Website: https://hoban.law
About Jeffrey Friedland
Jeffrey Friedland is an emerging market pioneer -- his firm, Friedland Global Capital, was one of the first American investment banks to establish a presence in China -- and is now on the front lines of the cannabis industry as an investor and business owner. He is an author, speaker and thought leader on emerging markets, the global economy, and the cannabis industry.
In his book, Marijuana, the World's Most Misunderstood Plant, Mr. Friedland dives into the world of marijuana, discussing what we know and what we still hope to discover. The book is available in print and Kindle editions at Amazon, http://www.amazon.com/author/jeffreyfriedland.
Mr. Friedland was an owner of two retail marijuana stores in Colorado which were located in the mountain resort towns of Breckenridge and Crested Butte, and a marijuana cultivation facility south of Steamboat Springs, which were featured in CNN's eight-part, reality series, High Profits.
He is also CEO of privately-held INTIVA Inc., which has operating businesses and investments in the cannabis industry in California, Colorado, Israel, and Canada. He is also CEO of INTIVA’s subsidiary, INTIVA BioPharma which is researching and developing cannabinoid-based drugs for various medical disorders and conditions. (www.INTIVABioPharma.com)
He is a board member of Israel-based CannRX, a company focused on the development of cannabis-based pharmaceuticals in Israel.
Mr. Friedland is a member of the advisory board of OWC Pharmaceutical Research (Stock Symbol: OWCP). INTIVA Inc. made an early-stage investment in OWC Pharmaceutical Research during the summer of 2014. (OWC Pharmaceuticals has developed and completed clinical trials in Israel for a CBD-based creme for the treatment of psoriasis.)
Jeffrey Friedland is also the CEO of Friedland Capital, which was formed in 1982.
Mr. Friedland has been the chief executive officer and a director of a NASDAQ listed financial services company, a director and chairman of the audit committee of a New York Stock Exchange listed company, and chairman of a company listed on the EU-regulated market of the Frankfurt Stock Exchange.
Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, Verslo Zinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, NBC.com, Breitbart, and Forbes.
Jeffrey Friedland's personal website: www.jeffreyfriedland.com.